The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women

被引:112
作者
Hampson, Geeta [1 ,2 ]
Edwards, Sylvie [2 ]
Conroy, Soraya [1 ]
Blake, Glen M. [2 ]
Fogelman, Ignac [2 ]
Frost, Michelle L. [2 ]
机构
[1] St Thomas Hosp, Dept Clin Chem, London SE1 7EH, England
[2] Kings Coll London, Osteoporosis Unit, London, England
关键词
Sclerostin; DKK1; Vascular calcification; Bone mineral density; MATRIX GLA PROTEIN; AORTIC CALCIFICATION; OSTEOPOROSIS; DISEASE; EXPRESSION; DKK1; PROGRESSION; MECHANISMS; PREDICTION; FRACTURES;
D O I
10.1016/j.bone.2013.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological studies have shown an association between bone loss/osteoporosis and vascular calcification (VC). Recent studies have implicated the Wnt signalling pathway in the pathogenesis of VC. We investigated the association between circulating concentrations of Wnt inhibitors; DKK1 and sclerostin with bone mineral density (BMD), abdominal aortic calcification (AAC) and arterial stiffness in post-menopausal women. One hundred and forty six post-menopausal women aged (mean [SD]) 61.5[6.5] years were studied. Sclerostin and DKK1 were measured in serum. BMD was measured at the lumbar spine (IS), femoral neck (FN), total hip (TH). MC was detected by Vertebral Fracture Assessment (VFA) imaging and quantified using an 8- and 24- point scoring methods. Arterial stiffness was determined by aortic pulse wave velocity (PWV). A significant positive correlation was observed between sclerostin and BMD at the FN (r = 0.166, p = 0.043) and TH (r = 0.165, p = 0.044). The association remained significant at the FN (p = 0.045) and TH (p = 0.026) following adjustment for confounders. No significant correlation was observed between DKK1 and BMD. In contrast, there was a significant negative correlation between log DKK1 and AAC (24-point score: r = 0.25, p = 0.008 and 8-point score: r = 0.21, p = 0.024). Subjects with MC score of 1 or less had significantly higher DKK1 (p = 0.01). The association between DKK1 and MC remained significant following correction for age, blood pressure, cholesterol (24-point score: p = 0.017, 8-point score: p = 0.044). In adjusted linear regression analysis, sclerostin was positively associated with MC (24-point score: p = 0.048, 8-point score: p = 0.031). Subjects with a PWV > 9 m/s had significantly higher sclerostin than those with PWV <9 m/s: 23.8[12.3], vs 29.7 [14] pmo1/1, p = 0.03). No association was observed between DKK1 and PWV. The opposite association between MC and the 2 Wnt signaling inhibitors is of interest and merits further investigations. Future longitudinal studies are needed to establish the precise role of sclerostin and DKK1 in the pathogenesis of VC. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 38 条
[1]   Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton [J].
Baron, Roland ;
Rawadi, Georges .
ENDOCRINOLOGY, 2007, 148 (06) :2635-2643
[2]   Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [J].
Baron, Roland ;
Hesse, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :311-325
[3]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[4]   The Role of Dkk1 in Bone Mass Regulation: Correlating Serum Dkk1 Expression with Bone Mineral Density [J].
Butler, Joseph S. ;
Murray, David W. ;
Hurson, Conor J. ;
O'Brien, Julie ;
Doran, Peter P. ;
O'Byrne, John M. .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2011, 29 (03) :414-418
[5]   Arterial Stiffening Relates to Arterial Calcification But Not to Noncalcified Atheroma in Women A Twin Study [J].
Cecelja, Marina ;
Jiang, Benyu ;
Bevan, Lisa ;
Frost, Michelle L. ;
Spector, Tim D. ;
Chowienczyk, Phil J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (13) :1480-1486
[6]   Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women [J].
Drake, Matthew T. ;
Srinivasan, Bhuma ;
Moedder, Ulrike I. ;
Peterson, James M. ;
McCready, Louise K. ;
Riggs, B. Lawrence ;
Dwyer, Denise ;
Stolina, Marina ;
Kostenuik, Paul ;
Khosla, Sundeep .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11) :5056-5062
[7]  
Garcia-Salcedo JA, 2013, DIABETES CARE
[8]   Sclerostin and DKK1 in Postmenopausal Osteoporosis Treated With Denosumab [J].
Gatti, Davide ;
Viapiana, Ombretta ;
Fracassi, Elena ;
Idolazzi, Luca ;
Dartizio, Carmela ;
Povino, Maria Rosaria ;
Adami, Silvano ;
Rossini, Maurizio .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (11) :2259-2263
[9]   Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss [J].
Gaudio, Agostino ;
Pennisi, Pietra ;
Bratengeier, Cornelia ;
Torrisi, Venerando ;
Lindner, Brigitte ;
Mangiafico, Roberto A. ;
Pulvirenti, Ivana ;
Hawa, Gerhard ;
Tringali, Giovanni ;
Fiore, Carmelo E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) :2248-2253
[10]   Vascular Smooth Muscle Cells in the Pathogenesis of Vascular Calcification [J].
Hruska, Keith A. .
CIRCULATION RESEARCH, 2009, 104 (06) :710-711